| 摘要 |
FR---6873 M (A) Cpds. (I) - where R1 is 1, 3, 4-oxadiazol-2-one, 1, 2, 4-triazol-3-one, tetrazole, or -COOR2; R2 is H or a group hydrolysable to H (aliphatic, aryl-aliphatic, alicyclic, or alicyclic-aliphatic, optionally with hetero-atoms); - (B) Acid-addition salts of cpds. (I), when R2 contains an N-heterocycle; (C) when R2 = H, base-addition salts of cpds. (I). - Anti-inflammatory and analgesic agents.
|
